FDA to ‘institutionalize’ compounding regulation to ‘protect consumers’ 19-Jun-2019 By Nick Taylor The US FDA is set to center its drug compounding regulatory program in an office focused on stopping poor quality, unsafe and ineffective drugs reaching patients.